PROFOUND MEDICAL CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PROFOUND MEDICAL CORP. (PROF) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$991.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.30M, a 631.43% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $311.00K, a 3.67% increase year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $40.00K, a 93.81% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$207.00K, a 130.62% decline year-over-year.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $378.00K, a 53.62% decline from fiscal 2024.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $815.00K, a 39.81% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.35M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$991.00K 10-Q · filed 2026-08-06 | -$951.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $311.00K 10-Q · filed 2026-05-07 | $351.00K derived: sum of 2 quarters · filed 2026-05-07 | $144.00K derived: sum of 3 quarters · filed 2026-05-07 | $389.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$167.00K derived: sum of 2 quarters · filed 2026-03-05 | $78.00K derived: sum of 3 quarters · filed 2026-08-06 | $378.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $38.00K derived: sum of 2 quarters · filed 2026-08-06 | $338.00K 10-Q · filed 2025-11-13 | $984.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $545.00K 10-Q · filed 2026-08-06 | $1.19M derived: sum of 3 quarters · filed 2026-08-06 | $1.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-07 | $946.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.62M derived: sum of 3 quarters · filed 2026-05-07 | $1.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.32M derived: sum of 2 quarters · filed 2026-03-05 | $1.39M derived: sum of 3 quarters · filed 2026-03-05 | $815.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $676.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $739.00K derived: sum of 2 quarters · filed 2025-11-13 | $169.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$507.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$570.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $1.35M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |